Home › Funds › WASATCH ADVISORS LP › HALO
WASATCH ADVISORS LP position in HALO
HALOZYME THERAPEUTICS INC · Health Care
WASATCH ADVISORS LP reported holding 1,049,647 shares of HALO (HALOZYME THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$115.9M, representing 0.86% of its reported portfolio and ranking #44 among its reported holdings. WASATCH ADVISORS LP first reported this position in Q3 2026.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How WASATCH ADVISORS LP's HALO position evolved
WASATCH ADVISORS LP first disclosed a stake in HALO in Q3 2026 at 1,049,647 shares (US$115.9M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 1.05M | $115.88M | New |
About HALO and 13F data
HALO (HALOZYME THERAPEUTICS INC) is a Health Care company. 42 other funds we track also report a position in HALO — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$251.9M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$196.5M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HALO
- CONGRESS ASSET MANAGEMENT CO 2.28M sh · $251.89M · Q3 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 2.51M sh · $196.54M · Q2 2026
- SNYDER CAPITAL MANAGEMENT L P 2.40M sh · $187.54M · Q2 2026
- LOS ANGELES CAPITAL MANAGEMENT LLC 1.94M sh · $151.69M · Q2 2026
- Stephens Investment Management Group LLC 1.39M sh · $109.02M · Q2 2026
- GW&K Investment Management, LLC 1.35M sh · $105.97M · Q2 2026
- Boston Trust Walden Corp 1.08M sh · $84.77M · Q2 2026
- LMR Partners LLP 45.00M sh · $65.81M · Q2 2026
- Mizuho Markets Cayman LP 834.50K sh · $65.32M · Q2 2026
More on WASATCH ADVISORS LP
FAQ
How long has WASATCH ADVISORS LP held HALO?
WASATCH ADVISORS LP has disclosed HALO holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is WASATCH ADVISORS LP's current position in HALO?
As of Q3 2026, WASATCH ADVISORS LP holds 1.05M shares of HALO (HALOZYME THERAPEUTICS INC), valued at $115.88M, representing 0.86% of its reported portfolio and ranking #44.
Has WASATCH ADVISORS LP been buying or selling HALO?
In the latest 13F filing (Q3 2026), WASATCH ADVISORS LP newly opened its position in HALO.
Which other funds hold HALO?
Other major institutional holders of HALO include CONGRESS ASSET MANAGEMENT CO, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, SNYDER CAPITAL MANAGEMENT L P, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.